University of Oklahoma Health Sciences Center

The flow of innovation in medical devices traditionally has been a one-way street. An engineer or a surgeon would identify a problem and create a potential solution, a twisted piece of metal that migh

by Ariana Del Negro and Mary Thompson For a number of reasons, 2009 was a big year for the atrial fibrillation (AF) ablation market. Early in the year, Biosense Webster Inc. (a division of Johns

In Vitro Diagnostics AdvanDx Inc. Series C for AdvanDx results in $15mm Sep. —Infectious disease diagnostics company AdvanDx raised $15mm in a Series C financing to its PNA FISH US distributor an

Marie Gethins More than 4,000 electrophysiologists (EPs) and cardiologists attended the biannual EuroPACE meeting in Lisbon, Portugal, at the end of June. While there was little to jolt the implantabl